The U.S. Food and Drug Administration

Summary : The U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a…

Synopsis: The U.S. Food and Drug Administration has approved Agios Pharmaceuticals’ candidate treatment for a rare type of hemolytic anemia. The regulator…